Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 23, 2019 at 12:12 PM.

  1. #1 cafead, Apr 23, 2019 at 12:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via As Bristol-Myers Squibb and Pfizer's superstar Eliquis continues to gobble up share in the warfarin alternative market, Bayer and Johnson & Johnson’s rival anticoagulant Xarelto is showing less-than-stellar prescription results.

    article source
     
    Quote

Reply to Thread